Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDViracta Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Viracta Therapeutics, Inc. Earnings Date And Information
Viracta Therapeutics, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.27 earnings per share for the quarter, missing analysts' consensus estimates of $-0.21 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Viracta Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.32 diluted earnings per share) and currently has a price-to-earnings ratio of -0.23. Viracta Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Viracta Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.21 | -$0.27 | -0.06 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$0.35 | -$0.25 | 0.1 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.35 | -$0.23 | 0.12 | $0 | |
| 03/07/2024 | Q4 2023 | -$0.30 | -$0.35 | -0.05 | $738,000 | |
| 11/09/2023 | Q3 2023 | -$0.33 | -$0.33 | 0 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.30 | -$0.32 | -0.02 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.34 | $0 | |||
| 03/14/2023 | Q4 2022 | -$0.27 | $0 | |||
| 11/10/2022 | Q3 2022 | -$0.31 | -$0.46 | -0.15 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.30 | -$0.28 | 0.02 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.32 | -$0.28 | 0.04 | $0 | |
| 03/16/2022 | Q4 2021 | -$0.31 | $0 | |||
| 11/10/2021 | Q3 2021 | -$0.31 | -$0.40 | -0.09 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.24 | -$0.25 | -0.01 | $0 | |
| 05/13/2021 | Q1 2021 | -$5.22 | $0 | |||
| 02/24/2021 | Q4 2020 | -$0.96 | -$0.41 | 0.55 | $0 | |
| 11/16/2020 | Q3 2020 | -$1.18 | -$0.11 | 1.07 | $0 | |
| 08/11/2020 | Q2 2020 | -$1.94 | -$0.11 | 1.83 | $375,000 | $0 |
| 05/07/2020 | Q1 2020 | -$2.44 | -$0.12 | 2.32 | $120,000 | |
| 03/10/2020 | Q4 2019 | -$2.58 | -$0.48 | 2.1 | $2.07 M |
Viracta Therapeutics, Inc. Earnings: FAQ's
When is Viracta Therapeutics, Inc.'s earnings date?
Viracta Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
How can I listen to Viracta Therapeutics, Inc.'s earnings conference
call?
The conference call for Viracta Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Viracta Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Viracta Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Viracta Therapeutics, Inc. generate each year?
Viracta Therapeutics, Inc. (:VIRX) has a recorded net income of $0. Viracta Therapeutics, Inc. has generated $-1.32 earnings per share over the last four quarters.
What is Viracta Therapeutics, Inc.'s price-to-earnings ratio?
Viracta Therapeutics, Inc. (:VIRX) has a price-to-earnings ratio of -0.23 and price/earnings-to-growth ratio is -0.04.